Resultats globals: 1 registres trobats en 0.03 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
10 p, 1.1 MB Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers : Present and Future / Heine, Renaud (Erasmus University Rotterdam) ; Thielen, Frederick W. (Erasmus University Rotterdam) ; Koopmanschap, Marc (Erasmus University Rotterdam) ; Kersten, Marie José (University of Amsterdam) ; Einsele, Hermann (Universitätsklinikum Würzburg) ; Jaeger, Ulrich (Medical University of Vienna) ; Sonneveld, Pieter (Erasmus University Rotterdam) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; Smand, Carin (European Hematology Association, The Hague) ; Uyl-de Groot, Carin A. (Institute for Medical Technology Assessment, Rotterdam) ; Universitat Autònoma de Barcelona
Since 2018, 2 chimeric antigen receptor (CAR) T-cell therapies received approval from the European Medicine Agency, with list prices around 320 000 Euro (€) (EUR) per treatment. These high prices raise concerns for patient access and the sustainability of healthcare systems. [...]
2021 - 10.1097/HS9.0000000000000524
HemaSphere, Vol. 5 (january 2021)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.